You may know there is a difference between corporate bonds and stocks and you may know it’s good to hold both stocks and bonds, but beyond these simple rules, do you understand how it all works? At the simplest level, stocks give investors part ownership in the business based on the number of shares they’ve bought. Bonds put money in investor’s pockets to finance business operation. It’s akin to a short-term loan made to the company by the bond buyer. Bonds pay interest over time, though they can also be traded.

"The Insider by DFIN" is a series of video interviews featuring the latest trends, topics and key perspectives on the global capital markets.

Join DFIN President and CEO Dan Leib as he shares his insights on DFIN’s transformation and future growth strategy in this special podcast edition of The Insider by DFIN.

Confluent is the data streaming platform that is pioneering a fundamentally new category of data infrastructure that sets data in motion. Their plans to go public became aligned with an unexpected disruption, stressing aggressive timelines, interrupting collaborative workflows, and complicating financial reporting.

Find out why Confluent chose DFIN as the one-stop-shop solution to help its dispersed staff manage and execute pre- and post-IPO requirements.

Catalent Pharma Solutions produces enormous data sets that require collaborative sharing among diverse internal and external stakeholders. Supporting these routine needs at the necessary security level is impossible using standard collaboration tools.

Find out why Catalent Pharma Solutions chose DFIN to support their needs with always-available Venue virtual data rooms (VDRs) that accelerate many business processes.

DFIN’s first quarter financial results, announced yesterday, indicate that our transformation into a software-centric company is shifting into high gear. Software sales represented 33% of total net sales in the quarter, the highest level in DFIN’s history. In addition, year-over-year sales growth for our software offerings was 15.8%, the fifth consecutive quarter of double-digit software sales growth.

Find out how DFIN’s Venue® Virtual Data Room helped Lunit successfully complete its Series C and Pre-IPO fundraising rounds during 2019-2021, raising over US$110M to strengthen its position as a global leading AI-powered cancer diagnosis firm.

CHICAGO – May 3, 2022 – Donnelley Financial Solutions (NYSE: DFIN), a leading global risk and compliance company, today announced that for the sixth consecutive year it has been named by Global M&A Network as “U.S.A. M&A Virtual Data Room Firm of the Year” for its Venue® solution. DFIN received this honor at the 13th annual special M&A Atlas Awards forum, held earlier this year. DFIN’s Venue Data Room (VDR) platform is designed to facilitate due diligence and eliminate risks that can compromise deals.

Making deals happens all the time in the oil and gas, power, and renewable energy sectors. Given the amount of highly confidential information involved — often including valuable trade secrets and IP — it’s important to be able to secure it throughout the process.

This is why Venue is the leading virtual data room for the energy industry. Using this platform’s enhanced security, companies within these verticals can share documents securely and safely without the risk of them falling into the wrong hands.

No sectors value confidentiality quite like healthcare, biotech, pharmaceuticals and life sciences. That’s why, when the time comes to concentrate on clinical trials, mergers and acquisitions, licensing agreements, and more, companies within these verticals trust Venue to be their healthcare virtual data room solution. This software enables secure sharing of documents to protect your information.

Our client, AprilBio, needed to confidentially connect with prospective licensees interested in licensing of its novel and well-differentiated asset which offers significant potential across a wide array of neuroimmune diseases. Information disclosed included proprietary and sensitive information such as preclinical data and exclusive R&D findings for new, potent therapies. Using a general-purpose file sharing service was deemed unacceptably risky.

Find out why AprilBio selected DFIN’s Venue® Virtual Data Room solution for this project.